T Cell Subsets in HIV Infected Patients after Successful Combination Antiretroviral Therapy: Impact on Survival after 12 Years
Research output: Contribution to journal › Journal article › Research › peer-review
Immune activation is decreased by combination antiretroviral therapy (cART) in patients infected with human immunodeficiency virus (HIV), but residual activation remains and has been proposed as a cause of premature aging and death, but data are lacking. We analyzed the relationship between T-cell subsets after 18 months of cART and overall survival during 12 years of follow up.
Original language | English |
---|---|
Journal | P L o S One |
Volume | 7 |
Issue number | 7 |
Pages (from-to) | e39356 |
ISSN | 1932-6203 |
DOIs | |
Publication status | Published - 2012 |
ID: 48451944